Health Condition 1: K30- Functional dyspepsia
Conditions
Interventions
Intervention1: Majoone-Sangdana Murgh: 5-10g Orally twice daily with
water after meals for 6 weeks
Control Intervention1: nil: nil
Sponsors
Central Council for Research in Unani Medicine CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: · Patients of either sex in the age group of 18-60 · Patients meeting the Rome III diagnostic criteria for PDS
Exclusion criteria
Exclusion criteria: · Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion. · Having overlap syndrome combined with gastro esophageal reflux disease or irritable bowel syndrome · Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.) · Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness · History of surgery related with the gastrointestinal tract more than six months ago · Taking drugs which may affect the gastro intestinal tract, such as non-steroidal antiinflammatory drugs and aspirin · Known Allergy to the experimental medications · Pregnant and breastfeeding · Refusing to sign the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Duâ??f al-Miâ??da (Functional Dyspepsia)Timepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigations will be done at baseline and end of treatmentTimepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed